Actualités et évènements

Clean Mails – Décembre 2024

Clean Biologics' News:
Next-Generation Sequencing, Single Cell Cloning, Exosomes, HIV vaccine...

Here is the last edition of our quaterly Clean Mails newsletter. To find out Clean Cells and Naobios' news or to receive our next editions, click here.

Clean Mails – June 2024

Clean Biologics' News:
CHO cell, Oncolytic Virus, Mass Spectrometry...

Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Leveraging CHO cell potential in R&D and cGMP". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.

Clean Mails

Clean Biologics' News:
Single cell cloning, rAAV, Human Viral Challenge Agents...

Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Clean Cells, your partner for single cell cloning to cGMP cell banks". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.

The quarterly scientific journal – October 2023

Clean Mails

Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Increasing biologics manufacturing capacities". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.

The quarterly scientific journal – June 2023

Clean Mails

Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Assessing the scale-X(TM) bioreactor's biomanufacturing capacities on Vero cells". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.

La revue scientifique trimestrielle – May 2023

Clean Mails

Vous trouverez ici le dernier numéro de notre newsletter trimestrielle Clean Mails, ayant comme sujet principal : "A new facility to extend biopharma services". Pour lire ce dossier et découvrir les actualités de Clean Cells, Naobios & Biodextris, ou recevoir les prochains numéros, cliquez ici :

Communiqué de presse

Clean Cells démarre les activités dans son nouveau bâtiment, le plus grand site dédié au contrôle qualité biopharmaceutique en Europe

Le bâtiment de 5 300 m2, qui représente un investissement de 22 millions d'euros, offre quatre fois plus d'espace de laboratoire que les installations historiques

Communiqué de Presse Biodextris

Biodextris investit dans un nouveau centre de développement et fabrication de produits biologiques (CDMO)

Biodextris investit dans un nouveau centre de développement et fabrication de produits biologiques (CDMO). Appui des gouvernements du Québec et du Canada ainsi que d’Investissement Québec.